Background & Aims Recently, international experts proposed redefining non-alcoholic fatty
liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD), …

Background Whether used for pain management or recreation, opioids have a number of
adverse effects including hormonal imbalances. These imbalances have been reported to …

Background Advances in genomics technology have led to a dramatic increase in the number
of published genetic association studies. Systematic reviews and meta-analyses are a …

Objective There is a significant interindividual variability in treatment outcomes in methadone
maintenance treatment (MMT) for opioid use disorder (OUD). This prospective cohort study …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the developed world, with a global prevalence of around 25%. NAFLD is considered to be …

Background Despite the growing numbers of men and women with opioid use disorder in
Canada, sex-specific issues in treatment have not been re-examined in the current population …

Public health concerns for the independent management of obesity and suicidal behavior are
rising. Emerging evidence suggests body weight plays an important role in quantifying the …

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic has affected the hospital experience for patients, visitors, and staff. Objective: To …

… The two raters (Dennis, B and Bawor, M) independently assessed the methodological quality
of each article using an amended Newcastle-Ottawa Scale for observational studies [39]. A …

Background We sought to determine if the publication of the Consolidated Standards of
Reporting Trials (CONSORT) 1 extension for abstracts in 2008 had led to an improvement in …